|Registry of biomedical companies:
[(]  [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 473 active entries
Phone: +45 39271771
Fax: +45 31200178
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.
Kem-En-Tec Diagnostics is Europe’s leading producer of ELISA substrates and buffers for immunoassays. We deliver ELISA, immunoblotting and immunohistochemistry components to biotech, pharmaceutical and immunoassay manufacturers and research laboratories in more than 30 countries worldwide. Kem-En-Tec Diagnostics enables IVD manufacturers and research labs to create their own safe, reliable kits for fast, accurate and early diagnosis.
Kem-En-Tec Diagnostics has pioneered the development of eco-sensible products (ECO-TEK). Environmentally-friendly components designed to significantly reduce facility water, waste and energy use without compromising quality, stability and accuracy. Likewise, we seek to eliminate the use of biological and chemical hazards commonly used in ELISA development and production.
Kem-En-Tec Diagnostics is a privately owned company founded by CEO and President Henrik Christensen and researchers from the Protein Laboratory of the University of Copenhagen in 1987. Company headquarters and the manufacturing facility are just outside of Copenhagen, Denmark. Kem-En-Tec Diagnostics USA is located in Windsor, Connecticut.
Our mission is to develop long term relationships with our customer. Our flexibility, from product development to packaging and delivery, enables us to tailor products and services to precisely meet any needs. We partner with our customers to improve the quality of their diagnostics and research, and in turn, benefit healthcare anywhere in the world.
We seek to develop and deliver the very best immunoassay components for IVD manufacturers and researchers worldwide. We strive to do this in an eco-sensible way to reduce the environmental impact of the healthcare industry without compromising quality, stability, and accuracy.
Last update of this entry: September 13, 2017